Cargando…

Streptavidin-biotin-based directional double Nanobody sandwich ELISA for clinical rapid and sensitive detection of influenza H5N1

BACKGROUND: Influenza H5N1 is one subtype of the influenza A virus which can infect human bodies and lead to death. Timely diagnosis before its breakout is vital to the human health. The current clinical biochemical diagnosis for influenza virus are still flawed, and the diagnostic kits of H5N1 are...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Min, Gong, Xue, Hu, Yonghong, Ou, Weijun, Wan, Yakun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274719/
https://www.ncbi.nlm.nih.gov/pubmed/25526777
http://dx.doi.org/10.1186/s12967-014-0352-5
_version_ 1782350025824665600
author Zhu, Min
Gong, Xue
Hu, Yonghong
Ou, Weijun
Wan, Yakun
author_facet Zhu, Min
Gong, Xue
Hu, Yonghong
Ou, Weijun
Wan, Yakun
author_sort Zhu, Min
collection PubMed
description BACKGROUND: Influenza H5N1 is one subtype of the influenza A virus which can infect human bodies and lead to death. Timely diagnosis before its breakout is vital to the human health. The current clinical biochemical diagnosis for influenza virus are still flawed, and the diagnostic kits of H5N1 are mainly based on traditional monoclonal antibodies that hardly meet the requirements for clinical applications. Nanobody is a promising tool for diagnostics and treatment due to its smallest size, high specificity and stability. In this study, a novel Nanobody-based bioassay was developed for rapid, low-cost and sensitive detection of the influenza H5N1 virus. METHODS: Nanobodies specific to H5N1 virus were selected from a VHH library by phage display technology. In this system, the biotinylated Nanobody was directionally captured by streptavidin coated on ELISA plate, which can specifically capture the H5N1 virus. Another Nanobody conjugated with HRP was used as a detector. A novel directional enzyme-linked immunosorbent assay for H5N1 using specific Nanobodies was established and compared to the conventional undirected ELISA assay. RESULTS: We have successfully constructed a high quality phage display Nanobody library and isolated two Nanobodies against H5N1 with high affinity and specificity. These two Nanobodies were further used to prepare the biosensor detection system. This streptavidin-biotin-based directional double Nanobodies sandwich ELISA for H5N1 detection showed superiority over the commonly undirectional ELISA protocol. The linear range of detection for standards in this immunoassay was approximately 50–1000 ng/mL and the detection limit was 14.1 ng/mL. The average recoveries of H5N1 virus from human serum samples were in the range from 94.58% to 114.51%, with a coefficient of variation less than 6.5%. CONCLUSION: Collectively, these results demonstrated that the proposed detection system is an alternative diagnostic tool that enables a rapid, inexpensive, sensitive and specific detection of the influenza virus.
format Online
Article
Text
id pubmed-4274719
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42747192014-12-24 Streptavidin-biotin-based directional double Nanobody sandwich ELISA for clinical rapid and sensitive detection of influenza H5N1 Zhu, Min Gong, Xue Hu, Yonghong Ou, Weijun Wan, Yakun J Transl Med Research BACKGROUND: Influenza H5N1 is one subtype of the influenza A virus which can infect human bodies and lead to death. Timely diagnosis before its breakout is vital to the human health. The current clinical biochemical diagnosis for influenza virus are still flawed, and the diagnostic kits of H5N1 are mainly based on traditional monoclonal antibodies that hardly meet the requirements for clinical applications. Nanobody is a promising tool for diagnostics and treatment due to its smallest size, high specificity and stability. In this study, a novel Nanobody-based bioassay was developed for rapid, low-cost and sensitive detection of the influenza H5N1 virus. METHODS: Nanobodies specific to H5N1 virus were selected from a VHH library by phage display technology. In this system, the biotinylated Nanobody was directionally captured by streptavidin coated on ELISA plate, which can specifically capture the H5N1 virus. Another Nanobody conjugated with HRP was used as a detector. A novel directional enzyme-linked immunosorbent assay for H5N1 using specific Nanobodies was established and compared to the conventional undirected ELISA assay. RESULTS: We have successfully constructed a high quality phage display Nanobody library and isolated two Nanobodies against H5N1 with high affinity and specificity. These two Nanobodies were further used to prepare the biosensor detection system. This streptavidin-biotin-based directional double Nanobodies sandwich ELISA for H5N1 detection showed superiority over the commonly undirectional ELISA protocol. The linear range of detection for standards in this immunoassay was approximately 50–1000 ng/mL and the detection limit was 14.1 ng/mL. The average recoveries of H5N1 virus from human serum samples were in the range from 94.58% to 114.51%, with a coefficient of variation less than 6.5%. CONCLUSION: Collectively, these results demonstrated that the proposed detection system is an alternative diagnostic tool that enables a rapid, inexpensive, sensitive and specific detection of the influenza virus. BioMed Central 2014-12-20 /pmc/articles/PMC4274719/ /pubmed/25526777 http://dx.doi.org/10.1186/s12967-014-0352-5 Text en © Zhu et al.; licensee BioMed Central. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Zhu, Min
Gong, Xue
Hu, Yonghong
Ou, Weijun
Wan, Yakun
Streptavidin-biotin-based directional double Nanobody sandwich ELISA for clinical rapid and sensitive detection of influenza H5N1
title Streptavidin-biotin-based directional double Nanobody sandwich ELISA for clinical rapid and sensitive detection of influenza H5N1
title_full Streptavidin-biotin-based directional double Nanobody sandwich ELISA for clinical rapid and sensitive detection of influenza H5N1
title_fullStr Streptavidin-biotin-based directional double Nanobody sandwich ELISA for clinical rapid and sensitive detection of influenza H5N1
title_full_unstemmed Streptavidin-biotin-based directional double Nanobody sandwich ELISA for clinical rapid and sensitive detection of influenza H5N1
title_short Streptavidin-biotin-based directional double Nanobody sandwich ELISA for clinical rapid and sensitive detection of influenza H5N1
title_sort streptavidin-biotin-based directional double nanobody sandwich elisa for clinical rapid and sensitive detection of influenza h5n1
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274719/
https://www.ncbi.nlm.nih.gov/pubmed/25526777
http://dx.doi.org/10.1186/s12967-014-0352-5
work_keys_str_mv AT zhumin streptavidinbiotinbaseddirectionaldoublenanobodysandwichelisaforclinicalrapidandsensitivedetectionofinfluenzah5n1
AT gongxue streptavidinbiotinbaseddirectionaldoublenanobodysandwichelisaforclinicalrapidandsensitivedetectionofinfluenzah5n1
AT huyonghong streptavidinbiotinbaseddirectionaldoublenanobodysandwichelisaforclinicalrapidandsensitivedetectionofinfluenzah5n1
AT ouweijun streptavidinbiotinbaseddirectionaldoublenanobodysandwichelisaforclinicalrapidandsensitivedetectionofinfluenzah5n1
AT wanyakun streptavidinbiotinbaseddirectionaldoublenanobodysandwichelisaforclinicalrapidandsensitivedetectionofinfluenzah5n1